Jupiter Topco LLC Buys Shares of 2,151,538 Lumexa Imaging Holdings, Inc. $LMRI

Jupiter Topco LLC bought a new position in Lumexa Imaging Holdings, Inc. (NASDAQ:LMRI) in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 2,151,538 shares of the company’s stock, valued at approximately $24,269,000.

Several other institutional investors and hedge funds also recently modified their holdings of LMRI. Strs Ohio bought a new position in Lumexa Imaging in the 1st quarter valued at about $38,000. Barclays PLC acquired a new position in shares of Lumexa Imaging in the fourth quarter worth about $133,000. PNC Financial Services Group Inc. purchased a new position in Lumexa Imaging during the 1st quarter worth approximately $63,000. Principal Financial Group Inc. grew its holdings in shares of Lumexa Imaging by 1.2% during the first quarter. Principal Financial Group Inc. now owns 664,136 shares of the company’s stock valued at $5,712,000 after buying an additional 7,875 shares in the last quarter. Finally, Sandia Investment Management LP acquired a new position in shares of Lumexa Imaging in the 4th quarter valued at about $185,000.

Lumexa Imaging Stock Down 1.9%

Shares of NASDAQ LMRI opened at $11.51 on Friday. The firm’s 50-day moving average is $11.40 and its 200-day moving average is $10.89. The company has a current ratio of 1.44, a quick ratio of 1.44 and a debt-to-equity ratio of 1.40. Lumexa Imaging Holdings, Inc. has a 1 year low of $6.45 and a 1 year high of $19.45. The firm has a market capitalization of $1.11 billion and a PE ratio of -23.49.

Lumexa Imaging (NASDAQ:LMRI) last posted its quarterly earnings results on Wednesday, August 12th. The company reported $0.20 earnings per share for the quarter, beating analysts’ consensus estimates of $0.03 by $0.17. The company had revenue of $264.16 million during the quarter. Lumexa Imaging has set its FY 2026 guidance at 0.710-0.770 EPS. Equities analysts expect that Lumexa Imaging Holdings, Inc. will post 0.25 EPS for the current year.

Analysts Set New Price Targets

Several analysts recently issued reports on the company. Barclays increased their price objective on Lumexa Imaging from $9.00 to $13.00 and gave the stock an “overweight” rating in a report on Friday. Wall Street Zen upgraded shares of Lumexa Imaging from a “hold” rating to a “buy” rating in a research note on Sunday, August 16th. Deutsche Bank Aktiengesellschaft set a $16.00 price target on shares of Lumexa Imaging in a report on Thursday, August 13th. Finally, Weiss Ratings upgraded shares of Lumexa Imaging from a “sell (e)” rating to a “sell (d)” rating in a research report on Thursday, June 25th. One equities research analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating and one has given a Sell rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $17.33.

Lumexa Imaging Profile

We are one of the largest national providers of diagnostic imaging services(1). Our platform is integrated, scalable and has a proven track record of creating value for our stakeholders. As of September 30, 2025, we and our affiliates operated the second largest(1) outpatient imaging center footprint in the United States. It spans 184 centers(2)across 13 states and includes eight joint venture partnerships with health systems. Our centers are in attractive metropolitan statistical areas (“MSAs”).